Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-055063

Chief Commercial Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Friedl-Naderer Johanna · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-12 Grant or award : show line 1 in the form +60,000 154,729 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-12 Grant or award : show line 2 in the form Stock option (right to buy) +90,000 90,000 D
Loading xslF345X05/ownership.xml…